Grade – This study is designed to help find the best combination drug treatment for people with type 2 diabetes. For more information please click here or please contact:
Sonia Guarda
984-974-3003
Theracos – The purpose of this study is to test a drug called Bexaglifozin for patients with Type 2 Diabetes that have an increased risk of cardiovascular disease. For more information please click here or contact:
Katarina Vukojicic
984-974-3008
Katarina_vukojicic@med.unc.edu
Derive – The purpose of this study is to evaluate the effectiveness of lowering blood sugar and kidney safety of Dapagliflozin in patients with Type 2 Diabetes and Chronic Kidney Disease (CKD 3A). For more information please click here or contact:
Katarina Vukojicic
984-974-3008
Katarina_vukojicic@med.unc.edu
Fidelio/Figaro - The purpose of this study is to investigate the effectiveness and safety of finerenone, a blood pressure medicine, in patients with Type 2 Diabetes and Diabetic Kidney Disease. For more information please click here or contact:
Katarina Vukojicic / Jamie Diner
984-974-3008 / 984-974-3017
Katarina_vukojicic@med.unc.edu / diner@med.unc.edu
Pioneer 7 – The purpose of this study is to look at the efficiency and safety of oral Semaglutide compare to Sitagliptin in subjects with Type 2 Diabetes. For more information contact:
Alex Kass
984-974-3009